Oncology | Pathology Prediction of recurrence risk in endometrial cancer with multimodal deep learning. May 24, 2024
Oncology | Pathology Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts. December 10, 2022